These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34264545)

  • 1. Weeding out the truth: a systematic review and meta-analysis on the transition from cannabis use to opioid use and opioid use disorders, abuse or dependence.
    Wilson J; Mills K; Freeman TP; Sunderland M; Visontay R; Marel C
    Addiction; 2022 Feb; 117(2):284-298. PubMed ID: 34264545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse Consequences of Co-Occurring Opioid Use Disorder and Cannabis Use Disorder Compared to Opioid Use Disorder Only.
    De Aquino JP; Sofuoglu M; Stefanovics E; Rosenheck R
    Am J Drug Alcohol Abuse; 2019; 45(5):527-537. PubMed ID: 31112429
    [No Abstract]   [Full Text] [Related]  

  • 5. The association between cannabis use and outcome in pharmacological treatment for opioid use disorder.
    Rosic T; Kapoor R; Panesar B; Naji L; Chai DB; Sanger N; Marsh DC; Worster A; Thabane L; Samaan Z
    Harm Reduct J; 2021 Feb; 18(1):24. PubMed ID: 33622351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabis-based medicines for chronic neuropathic pain in adults.
    Mücke M; Phillips T; Radbruch L; Petzke F; Häuser W
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012182. PubMed ID: 29513392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to Bahji et al.: Limitations of the available evidence that restrict our interpretation of the transition from cannabis to opioid use.
    Wilson J; Mills KL; Freeman TP; Sunderland M; Visontay R; Marel C
    Addiction; 2022 Oct; 117(10):2754-2755. PubMed ID: 35792056
    [No Abstract]   [Full Text] [Related]  

  • 8. A Systematic Review of Attention Biases in Opioid, Cannabis, Stimulant Use Disorders.
    Zhang M; Ying J; Wing T; Song G; Fung DSS; Smith H
    Int J Environ Res Public Health; 2018 Jun; 15(6):. PubMed ID: 29857586
    [No Abstract]   [Full Text] [Related]  

  • 9. Risk and benefit of cannabis prescription for chronic non-cancer pain.
    Zloczower O; Brill S; Zeitak Y; Peles E
    J Addict Dis; 2022; 40(2):157-167. PubMed ID: 34338621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant cannabis abuse/dependence in patients treated with opioids for non-cancer pain.
    Hefner K; Sofuoglu M; Rosenheck R
    Am J Addict; 2015 Sep; 24(6):538-45. PubMed ID: 26246069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is Cannabis being used as a substitute for non-medical opioids by adults with problem substance use in the United States? A within-person analysis.
    Gorfinkel LR; Stohl M; Greenstein E; Aharonovich E; Olfson M; Hasin D
    Addiction; 2021 May; 116(5):1113-1121. PubMed ID: 33029914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using Mendelian randomization to explore the gateway hypothesis: possible causal effects of smoking initiation and alcohol consumption on substance use outcomes.
    Reed ZE; Wootton RE; Munafò MR
    Addiction; 2022 Mar; 117(3):741-750. PubMed ID: 34590374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-reported pain severity and use of cannabis and opioids in persons with HIV in an urban primary care setting in Northern California: A cross-sectional study.
    Kim HJ; Satre DD; Leyden W; Leibowitz AS; Campbell CI; Silverberg MJ
    Medicine (Baltimore); 2024 Mar; 103(13):e37581. PubMed ID: 38552034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of iatrogenic opioid dependence or abuse in patients with pain who were exposed to opioid analgesic therapy: a systematic review and meta-analysis.
    Higgins C; Smith BH; Matthews K
    Br J Anaesth; 2018 Jun; 120(6):1335-1344. PubMed ID: 29793599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Problematic Use of Opioids in Patients with Chronic Noncancer Pain: A Systematic Review with Meta-analysis.
    Jantarada C; Silva C; Guimarães-Pereira L
    Pain Pract; 2021 Jul; 21(6):715-729. PubMed ID: 33528858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of comorbid substance use disorders among people with opioid use disorder: A systematic review & meta-analysis.
    Santo T; Gisev N; Campbell G; Colledge-Frisby S; Wilson J; Tran LT; Lynch M; Martino-Burke D; Taylor S; Degenhardt L
    Int J Drug Policy; 2024 Jun; 128():104434. PubMed ID: 38677160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabis use to manage opioid cravings among people who use unregulated opioids during a drug toxicity crisis.
    Reddon H; Lake S; Socias ME; Hayashi K; DeBeck K; Walsh Z; Milloy MJ
    Int J Drug Policy; 2023 Sep; 119():104113. PubMed ID: 37481875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between speed of transition from initiation to subsequent use of cannabis and later problematic cannabis use, abuse and dependence.
    Hines LA; Morley KI; Strang J; Agrawal A; Nelson EC; Statham D; Martin NG; Lynskey MT
    Addiction; 2015 Aug; 110(8):1311-20. PubMed ID: 25917230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of problematic pharmaceutical opioid use in patients with chronic non-cancer pain: A systematic review and meta-analysis.
    Thomas KH; Dalili MN; Cheng HY; Dawson S; Donnelly N; Higgins JPT; Hickman M
    Addiction; 2024 Nov; 119(11):1904-1922. PubMed ID: 39111346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.